IDEXX Laboratories

IDEXX Laboratories ROE

The Return on Equity (ROE) of IDEXX Laboratories (IDXX) as of Oct 30, 2026 is 65.99 %. In the previous year, Return on Equity (ROE) was 55.65 % — a change of 18.58% (higher).

ROE

65.99 %

YoY

18.58%

Last updated:

In 2025, IDEXX Laboratories's return on equity (ROE) was 65.99 %, a 18.58% increase from the 55.65 % ROE in the previous year.

The IDEXX Laboratories ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
-3,963.32 USD
Jan 1, 2019
241.01 USD
Jan 1, 2020
92.04 USD
Jan 1, 2021
107.95 USD
Jan 1, 2022
111.56 USD
Jan 1, 2023
56.92 USD
Jan 1, 2024
55.65 USD
Jan 1, 2025
65.99 USD
The IDEXX Laboratories ROE history
YEARROEYoY
65.99 %+18.58%
55.65 %-2.23%
56.92 %-48.97%
111.56 %+3.34%
107.95 %+17.29%
92.04 %-61.81%
241.01 %-106.08%
-3,963.32 %+714.91%
-486.35 %+137.33%
-204.93 %-10.25%
-228.32 %-247.50%
154.79 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

IDEXX Laboratories Stock analysis

What does IDEXX Laboratories do? The history of IDEXX Laboratories Inc began in 1983 when a research team from the University of Maine developed technology for the automatic analysis of animal blood. The first products were soon sold and the company grew rapidly. Today, IDEXX is a leading global provider of veterinary diagnostic and IT solutions, recognized by customers in over 175 countries. IDEXX's business model is based on innovation and a comprehensive understanding of the needs of veterinarians and their patients. The company offers a wide range of products and solutions that make the diagnosis and treatment of animal diseases easier and more reliable. These include tests and devices for blood analysis, urine and stool diagnostics, as well as imaging, infection control, and cancer diagnostics. The company has several divisions that focus on different aspects of veterinary diagnostics. IDEXX Diagnostics is the largest business segment, offering veterinary lab services, diagnostic tests, and software solutions. IDEXX Water is a company specializing in the analysis of water samples and monitoring of environmental conditions. IDEXX Livestock, the newest division of IDEXX, provides veterinary solutions for agricultural and livestock operations. Key products of IDEXX include tests for parasites, infections, diabetes, and kidney function. The company has also developed some innovative products, such as SNAP tests, which provide fast and accurate results and can perform tests for various pathogens simultaneously. IDEXX is also a company committed to sustainability. The IDEXX Foundation was established in 2013 and has since donated over $32 million to local and global projects that aim to protect animals and the environment. Overall, IDEXX Laboratories Inc is a company specialized in veterinary diagnostic and IT solutions to support veterinarians in treating animals. The wide range of solutions and products, as well as the commitment to sustainability, make the company an important player in the market for veterinary diagnostics. IDEXX Laboratories is one of the most popular companies on Eulerpool.

ROE Details

Decoding IDEXX Laboratories's Return on Equity (ROE)

IDEXX Laboratories's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing IDEXX Laboratories's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

IDEXX Laboratories's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in IDEXX Laboratories’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about IDEXX Laboratories stock

Return on Equity (ROE) of IDEXX Laboratories is 65.99 % in 2025.

Return on Equity (ROE) of IDEXX Laboratories changed from 55.65 % to 65.99 %, representing a 18.58% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) IDEXX Laboratories since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s IDEXX Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — IDEXX Laboratories

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — IDEXX Laboratories